PerkinElmer, Inc.

    Jurisdiction
    United States
    LEI
    549300IKL1SDPFI7N655
    ISIN
    US7140461093 (PKI)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    InsiderPie Expert Score
    52 / 100
    Worse than peer group:
    61 / 100
    Fair value (Benjamin Graham formula)
    €86.25 9.9% undervalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. Read full profile

    Fundamentals

    Net revenue
    €2.30B
    Gross margin
    64.0%
    EBIT
    €292.52M
    EBIT margin
    12.7%
    Net income
    €249.95M
    Net margin
    10.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.52B +9.3% €521.18M +108.5%
    €2.67B +5.9% €573.98M +10.1%
    €2.83B +6.0% €617.63M +7.6%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.07
    Ex date
    Payment date
    Dividend payout ratio
    14.7%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    MICHAS ALEXIS P N/A -500 $89.01 -$44.51K

    Earnings Calls

    Earnings Calls

    Latest earnings call: February 1, 2024 (Q4 2023)

    Add to watchlist

    Notifications